Skip to main content
Clinical Trials/NL-OMON42228
NL-OMON42228
Completed
N/A

An early clinical feasibility study of a new prosthesis: the NewBreez® Intralaryngeal device; a possible solution for severe aspiration in head and neck cancer patients - An intralaryngeal device for a dysfunctional larynx

Antoni van Leeuwenhoek Ziekenhuis0 sites5 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
aspiration
Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Enrollment
5
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Antoni van Leeuwenhoek Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • \- Patients who have been treated successfully for HNC and are free of disease minimally one year after treatment; and
  • \- Patients with difficulties in feeding and/or breathing due to a dysfunctional larynx, necessitating prolonged (\> 6 months) use of a (nasogastric or percutaneous) feeding tube and a tracheotomy, which are unlikely to be removed; and
  • \- Patients who are motivated to undergo the operation; and
  • \- Patients are willing to provide written informed consent prior to participation.

Exclusion Criteria

  • \- Patients under the age of 18 years; or
  • \- Patients with clotting disorders; or
  • \- Patients with Chronic Obstructive Pulmonary Disease (COPD); or
  • \- Patients with recurrent or residual HNC disease; or
  • \- Patients with upper esophageal obstruction or stenosis on videofluoroscopy; or
  • \- Patients who are unfit to undergo general anaesthesia, as judged by the anaesthetist.

Outcomes

Primary Outcomes

Not specified

Similar Trials